MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Tuesday, April 26, 2016 - 11:30
in Health & Medicine
Cancer researchers at the University of Cincinnati (UC) have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.